This Community is Archived.

This community is no longer active as of December 2018. Thanks to those who posted here and made this information available to others visiting the site.

March 7-11 GHDonline to host Virtual Panel Discussion around PrEP as a novel approach to prevention.

By Sarah Arnquist | 01 Mar, 2011 Last edited by Sarah Arnquist on 08 Apr 2011

On the heels of CROI 2011 and in partnership with MGH's HOPE Conference Series, GHDonline’s HIV prevention community is hosting a “virtual expert panel” March 7-11 to continue discussing PrEP as a novel approach to prevention.

Panelists from Uganda, South Africa and the United States will add discussions to the online community, highlighting various barriers and opportunities to implementing PrEP in clinical settings; how to encourage long-term adherence; and what additional research questions need to be answered.

All GHDonline members can participate in this virtual discussion. Sign up here if you haven’t already joined and keep your email settings to “per post” to track the discussion live in your inbox.

Panelists:

Douglas Krakower, MD is a fellow in Infectious Diseases at Beth Israel Deaconess Medical Center/Harvard Medical School

Andrew Mujugira, MBChB, MSc is the East Africa regional medical director for the Partners PrEP study.

Vivek Naranbhai, PhD, was involved in CAPRISA microbicide gel study.

 

This Community is Archived.

This community is no longer active as of December 2018. Thanks to those who posted here and made this information available to others visiting the site.